Cidofovir dosage in a critically ill patient undergoing continuous veno-venous hemodiafiltration
Saved in:
Main Authors: | H. Anglada Martínez (Author), E. Carcelero San Martín (Author), P. Castro Rebollo (Author), D. Soy Muner (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2014-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk factors for mortality in patients with acute kidney injury and hypotension treated with continuous veno-venous hemodiafiltration
by: In Myung Oh, et al.
Published: (2012) -
The Impact of Continuous Veno-Venous Hemodiafiltration on the Efficacy of Administration of Prophylactic Doses of Enoxaparin: A Prospective Observational Study
by: Aleksander Aszkiełowicz, et al.
Published: (2023) -
Real-Time TDM-Based Expert Clinical Pharmacological Advice Program for Attaining Aggressive Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Meropenem in the Treatment of Critically Ill Patients with Documented Gram-Negative Infections Undergoing Continuous Veno-Venous Hemodiafiltration
by: Milo Gatti, et al.
Published: (2023) -
Pharmacokinetic Analysis of Meropenem and Piperacillin in Critically-Ill Patients Requiring Continuous Ven-Venous Hemodiafiltration
by: Brandon Ferlas, et al.
Published: (2015) -
Effect of Phoxilium on prognostic predictors in patients undergoing continuous venovenous hemodiafiltration
by: Da Woon Kim, et al.
Published: (2021)